How a deployment gets into the tracker
What we accept as evidence, how stages work, what we record about regulation, and how to correct us.
In short
- No public source, no entry.
- Every entry has exactly one stage, and it only moves when a new source shows the change.
- We report what sources say, including the hospital’s own claims, and label them as such.
1. What counts as a deployment
An AI system used, or formally planned for use, in the care of patients or in the clinical work around it at a named European hospital, clinic, trust, health board or national health service. That includes tools that draft clinical notes, read images, predict deterioration, triage patients, support decisions, communicate with patients or run hospital operations.
We do not track research projects with no patient-facing use, vendor announcements that name no healthcare organisation, or consumer apps used outside a care provider.
2. Sources we accept
- Statements, board papers and press releases from the healthcare organisation itself.
- Public procurement notices, tenders and framework agreements.
- Reporting by health-technology and general news outlets.
- Peer-reviewed papers and reports from public bodies such as the OECD, WHO or national agencies.
- Vendor case studies, but only when the named organisation is identifiable, and we label the source as a vendor.
Every entry links to its source and shows the source’s date. When a source reports results, such as time saved or productivity gains, we attribute them to whoever claimed them. We do not verify those results ourselves.
3. The five stages
| Stage | Meaning | Typical evidence |
|---|---|---|
| Announced | Plans, tenders, contracts or partnerships made public | Contract award, framework, board decision |
| Pilot | Tested with limited patients, sites, services or time | Pilot launch or evaluation report |
| Rolling out | Expanding beyond the pilot into routine use | Organisation-wide rollout announced |
| Live | Part of standard care at the named site | Reported routine use with outcomes or volumes |
| Paused / ended | Stopped, withdrawn or not renewed | Statement, contract end, or reporting |
4. Regulation fields
Many clinical AI tools are medical devices under the EU Medical Device Regulation (MDR) or the In Vitro Diagnostic Regulation (IVDR). Under the EU AI Act, AI that is, or is part of, such a device and needs a notified body is generally high-risk, and hospitals using it are deployers with their own duties. Where a source states a tool’s CE marking class or AI Act status, we record it. Where it does not, we leave the field empty rather than guess.
5. Corrections
Hospitals, vendors and readers can correct any entry by sending a source to contact@eurohealthcamp.com or through the submission form. We reply to every correction request and date significant changes.
6. Independence
No vendor pays for inclusion, placement or wording. See our editorial policy.